The global cell culture market is expected to reach USD 37.0 billion by 2022,
according to a new report by Grand View Research, Inc. This expected growth in
demand can be ascribed to the growing need for biopharmaceutical development,
vaccine research and development, and protein production; all of which rely
heavily on cytological R&D in which cell culture plays a pivotal
role.
The development and commercialization of integrated robotic liquid
handling laboratory automation culture systems is also expected to considerably
enhance growth over the forecast period. These systems provide highly improved
capacity handling, higher efficiency and reproducible purity levels.
Browse full report
by Grand View Research : http://www.grandviewresearch.com/industry-analysis/cell-culture-market
Further key
findings from the report suggest:
·
Cell culture
sera accounted for over 50% of revenue generated in 2014 owing to, high usage
rates of serum in the composition of cell cultures and their relatively high
average market prices. Furthermore, commercialization of serum free sera is
also expected to drive market demand in the coming years.
·
Culture reagents
including amino acids, cofactors, thrombin, and growth factors, even though
used in trace quantities, account for a considerably large share of revenue
owing to their relatively expensive prices.
·
North America
accounted for the largest share of this market in 2014, as there are a
significantly high number of research and development projects ongoing in the
region related to cytological investigation for proteomics, genomics, and drug
and vaccine development. Growing need for biopharmaceuticals is also
anticipated to fuel regional market growth during the forecast period.
·
Rising demand,
for cell culture technology and cell biology research in Europe has shown
significant development and companies have started investing in innovative
technologies and advances in cell culture applications.
·
Asia Pacific is
expected to witness significant growth in demand over the forecast period owing
to the presence of high unmet need for increasing production and development of
vaccines, drugs, and new biologics. Supportive government initiatives
pertaining to increasing investments by manufacturers and governments in
biopharmaceutical manufacturing and high untapped market opportunities are some
important factors accounting for such rapid growth in demand.
·
Key participants
of the cell culture market include Sartorius, Thermo Fisher Scientific, General
Electric, Merck, Sigma-Aldrich Co., LLC, Corning, Lonza, Promocell, Becton,
Dickinson & Company, and Eppendorf.
·
Market
participants are involved in extensive R&D of 3D cell culture and full
commercialization of the technologically advanced cell culture which offer
higher accuracy of replication, greater purity and rapid growth
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell culture market on the basis of
consumables, products, applications and regions:
Cell Culture Consumables Outlook
(Market Revenue in USD Billion, 2012 - 2022 )
·
Media
o Minimum Essential Media (MEM)
o RPMI 1640 Media
o DMEM/F-12 Media
o F-10 Serum Free Media
o BME Media
o Insect Media
o Other Media
·
Sera
o Fetal Bovine Serum
o Other Animals’ serum
·
Reagents
o Albumin
o Other
Cell Culture Product Outlook (Market
Revenue in USD Billion, 2012 - 2022 )
·
Culture Systems
·
Incubators
·
Centrifuges
·
Pipetting
Instruments
·
Biosafety
Equipment
·
Cryostorage
Equipment
Cell Culture Applications Outlook
(Market Revenue in USD Billion, 2012 - 2022 )
·
Biopharmaceuticals
·
Cancer Research
·
Drug Development
·
Gene Therapy
·
Tissue Culture
& Engineering
·
Toxicity testing
·
Vaccine
Production
Cell Culture Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
View Press Release Of This Report by Grand View
Research: http://www.grandviewresearch.com/press-release/global-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment